Eagle Pharmaceuticals
EGRX
#11054
Rank
HK$25.78 M
Marketcap
HK$1.96
Share price
0.00%
Change (1 day)
-92.12%
Change (1 year)

Market capitalization of Eagle Pharmaceuticals (EGRX)

Market cap: HK$25.78 Million

As of August 2026 Eagle Pharmaceuticals has a market cap of HK$25.78 Million. This makes Eagle Pharmaceuticals the world's 11054th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Eagle Pharmaceuticals from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$25.78 M-43.16%
2025HK$45.37 M-18%
2024HK$55.33 M-89.57%
2023HK$0.53 B-82.15%
2022HK$2.97 B-42.03%
2021HK$5.12 B9%
2020HK$4.70 B-26.24%
2019HK$6.37 B45.28%
2018HK$4.38 B-29.51%
2017HK$6.22 B-34.59%
2016HK$9.52 B-11.4%
2015HK$10.74 B536.79%
2014HK$1.68 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
HK$5.160 T 20,010,908.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$2.384 T 9,244,062.06%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
HK$8.625 T 33,443,982.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$1.874 T 7,268,397.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$1.087 T 4,217,741.44%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$817.63 B 3,170,279.57%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
HK$348.09 B 1,349,627.70%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel